| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.80B | 28.89B | 20.78B | 15.11B | 10.78B | 7.07B |
| Gross Profit | 13.95B | 12.86B | 9.58B | 7.59B | 5.20B | 3.00B |
| EBITDA | 3.35B | 3.56B | 3.21B | 2.25B | 1.32B | 674.00M |
| Net Income | 1.92B | 2.00B | 1.91B | 987.00M | 482.00M | 83.00M |
Balance Sheet | ||||||
| Total Assets | 46.93B | 42.67B | 25.20B | 17.61B | 13.74B | 10.10B |
| Cash, Cash Equivalents and Short-Term Investments | 5.46B | 6.30B | 3.75B | 3.75B | 3.03B | 2.79B |
| Total Debt | 12.35B | 11.39B | 6.85B | 5.33B | 5.41B | 3.98B |
| Total Liabilities | 39.65B | 35.92B | 20.84B | 14.54B | 11.91B | 8.57B |
| Stockholders Equity | 7.28B | 6.75B | 4.35B | 3.07B | 1.83B | 1.53B |
Cash Flow | ||||||
| Free Cash Flow | 10.71B | 10.77B | 7.06B | 4.63B | 2.48B | 355.55M |
| Operating Cash Flow | 11.95B | 12.12B | 7.92B | 5.14B | 2.94B | 965.04M |
| Investing Cash Flow | -5.34B | -6.18B | -8.29B | -3.45B | -3.87B | -1.60B |
| Financing Cash Flow | 3.18B | 2.90B | 1.96B | -267.00M | 916.00M | 1.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $120.19B | 8.39 | 24.04% | ― | 11.69% | -1.85% | |
76 Outperform | $48.52B | 24.00 | 44.12% | 1.38% | 13.15% | 5.89% | |
73 Outperform | $55.45B | 34.36 | 14.24% | ― | 40.54% | 78.98% | |
71 Outperform | $85.96B | 44.77 | 29.58% | ― | 42.11% | -6.84% | |
66 Neutral | $6.45B | 22.95 | -25.47% | ― | 1.78% | 75.71% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | $29.80B | -183.61 | -3.67% | ― | 13.10% | -163.64% |